A multipotent precursor in the thymus maps to the branching point of the T versus B lineage decision by Benz, Claudia & Bleul, Conrad C.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
 
JEM © The Rockefeller University Press $8.00
Vol. 202, No. 1, July 4, 2005 21–31 www.jem.org/cgi/doi/10.1084/jem.20050146
 
ARTICLE
 
21
 
A multipotent precursor in the thymus maps 
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Hematopoietic precursors continuously colonize the thymus where they give rise mainly to 
T cells, but also to B and dendritic cells. The lineage relationship between these three cell 
types is unclear, and it remains to be determined if precursors in the thymus are 
multipotent, oligopotent, or lineage restricted. Resolution of this question necessitates the 
determination of the clonal differentiation potential of the most immature precursors in the 
thymus. Using a CC chemokine receptor 9–enhanced green fluorescent protein knock-in 
allele like a surface marker of unknown function, we identify a multipotent precursor 
present in bone marrow, blood, and thymus. Single cells of this precursor give rise to T, B, 
and dendritic cells. A more differentiated stage of this multipotent precursor in the thymus 
has lost the capacity to generate B but not T, dendritic, and myeloid cells. Thus, the newly 
identified precursor maps to the branching point of the T versus B lineage decision in the 
hematopoietic lineage hierarchy.
 
T lymphocytes that develop in the thymus are
derived from a pool of self-renewing, multipo-
tent hematopoietic stem cells (HSCs) that
lodge in the bone marrow (1). T cell develop-
ment in the thymus is replenished continuously
by hematopoietic precursors that travel from
the bone marrow via blood to the thymus be-
cause the thymus does not support precursors
with the capacity for self-renewal (2). The nature
of these precursors is still controversial. Many
hematopoietic precursors in the bone marrow
with distinct self-renewal capacities and differ-
entiation potentials generate T cells upon
adoptive transfer of irradiated hosts (e.g.,
HSCs [3], early lymphoid progenitors [4],
Lin
 
 
 
Sca-1
 
 
 
c-kit
 
 
 
 (LSK)flt3
 
 
 
s [5] and com-
mon lymphoid progenitors [CLPs; reference
6]), but none of these has been demonstrated
to lodge in the thymus. Therefore, it remains
to be determined at which level of the hemato-
poietic lineage hierarchy thymopoiesis branches
off. Even the question if thymic precursors are
multipotent, oligopotent, or lineage-restricted,
and if they commit to the T cell lineage in the
bone marrow or in the thymus remains con-
troversial because adult thymic precursors only
have been studied on the population level.
There is good evidence that hematopoietic
precursors in the thymus produce T, B (7, 8),
and dendritic cells (9). Whether these cells derive
from a single, oligopotent progenitor or from
distinct, precommitted precursor cells is unre-
solved, although the existence of a T/B pre-
cursor was suggested by the predominant
generation of B cells by Notch1-deficient pre-
cursor cells (10, 11). Resolution of these ques-
tions necessitates the identification of the most
immature hematopoietic precursor in the thy-
mus, and the determination of its clonal differ-
entiation potential.
In 1991, Wu et al. (12) identified the
“CD4
 
low
 
 precursor” among adult thymo-
cytes which was characterized further as a
Lin
 
 
 
CD25
 
 
 
CD44
 
hi
 
 c-kit
 
hi
 
 cell by others (13).
With notable exceptions (14, 15), this population
is still viewed as the most immature stage of T
cell development which among coreceptor CD4
and CD8 double-negative (DN) thymocytes fol-
lows the sequence DN1 (c-kit
 
 
 
CD44
 
 
 
CD25
 
 
 
)
to DN2 (c-kit
 
 
 
CD44
 
 
 
CD25
 
 
 
) to DN3 (c-
kit
 
 
 
CD44
 
 
 
CD25
 
 
 
) to DN4 (c-kit
 
 
 
CD44
 
 
 
CD25
 
 
 
;
references 16–19). Recently, Allman et al.
showed that IL-7R-expressing cells among
CD4
 
low
 
 precursors do not contain T lineage
potential and termed the remaining DN1
Lin
 
 
 
c-kit
 
hi
 
IL-7R
 
neg/lo
 
 cells “early T lineage pro-
genitors” (ETPs; reference 20). ETPs constitute
87% of CD4
 
low
 
 precursors and are functionally
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indistinguishable because they contain mainly T lineage pre-
cursors and a few B and myeloid progenitors (8, 20, 21). The
most immature hematopoietic precursors in the thymus are
believed to be contained in the ETP population, because the
only population with potent T lineage potential in the blood
of adult mice carries the Lin
 
 
 
 Sca-1
 
 
 
 c-kit
 
 
 
 (LSK) surface
markers that also are found on ETPs (22), but not other pre-
sumptive precursors (14, 15). Because 10,000 ETPs can be
found in the thymus of an adult mouse, the ETP population
is far too numerous to consist homogeneously of thymic
precursors (23); the niche that contains thymus repopulating
cells is believed to contain only a few hundred cells (24, 25).
The large number of these cells per thymus, and the fact that
ETPs in the blood cannot be separated from HSCs and other
multipotent precursors that are not found in the thymus by
conventional surface markers (22) has hampered the investi-
gation of lineage relationships of hematopoietic cells in the
thymus. Thus, markers that distinguish functional popula-
tions within the ETP population are called for. A recent re-
port confirms that the only DN1 subsets that are less mature
than DN2 thymocytes carry the ETP phenotype and distin-
guishes a DN1a and a DN1b subset by CD24 expression
(26). In contrast to ETPs, the DN1a and DN1b subsets lack
B potential; this suggests the independent immigration of B
precursors and the most immature T lineage progenitors
within separate precursor populations. Thus, the identity and
the functional properties of the most immature precursors
within the large ETP population are unclear.
To investigate whether mature T, B, and dendritic cells
derive from a single, oligopotent progenitor or from distinct,
precommitted precursor cells, we enhanced GFP (EGFP)-
tagged T lineage cells by their expression of the CC chemo-
kine receptor 9 (CCR9) that is expressed exclusively at sites
of T cell development (27–29). By following EGFP
 
CCR9
 
expression in heterozygous CCR9-EGFP knock-in mice
in which adult 
 
  
 
-T cell development is indistinguishable
from wild-type thymopoiesis, we now identify a thymic
precursor that gives rise to T cells, B cells, and dendritic
cells on the single cell level. Furthermore, we supply evi-
dence that this progenitor maps to the branching point of
the T versus B lineage decision in the hematopoietic lin-
eage hierarchy.
 
RESULTS
Regulation of EGFP
 
CCR9
 
 expression during the early steps of
T cell development
 
To reinvestigate the issue of the most immature precursor in
the thymus, we sought to develop a novel marker for thymic
precursors. Therefore, we tagged T lineage cells by their ex-
pression of CCR9 that is expressed exclusively at sites of T
cell development (27–29). To this end, we generated mice
in which the NH
 
2
 
-terminal half of the CCR9 coding region
is replaced in frame by an EGFP cassette (30). Expression of
the tag in the correct cell types was confirmed by FACS
analysis of EGFP
 
CCR9
 
 in heterozygous CCR9-EGFP knock-
in mice, in which adult 
 
  
 
-T cell development is indistin-
guishable from wild-type thymopoiesis (Fig. S1, available
at http://www.jem.org/cgi/content/full/jem.20050146/
DC1). Cytoplasmic EGFP and membrane integral CCR9
can be expected to show widely divergent half-lives. There-
fore, we considered EGFP
 
CCR9
 
 expression as a T cell precur-
sor identifying tag, just like a surface marker of unknown
function. We did not take its presence as evidence for the
Figure 1. EGFPCCR9 expression of early stages of thymopoiesis in 
heterozygous CCR9-EGFP knock-in embryos. (A) Identification of 
EGFPCCR9-expressing cells in embryonic organs at E11.5 and E12.5 was 
done by analyzing single cell suspensions of the respective tissues by flow 
cytometry. The third pharyngeal pouch containing the thymic anlage was 
analyzed at E11.5. The percentage of EGFPCCR9-positive cells is indicated. 
Cell numbers are plotted as total number of cells. (B) Flow cytometric 
analysis of the earliest immigrants to the embryonic thymic anlage of het-
erozygous CCR9-EGFP knock-in embryos was performed for embryonic 
days 11.5 through 15.5. To avoid contaminating mature cells that were 
derived from the peripheral blood, the dot plots for E11.5 and E12.5 are 
gated on lymphoid cells negative for markers of lineage differentiation, 
including B220, CD3 , CD4, CD8, CD11b, Gr-1, Ter119, TCR  , and NK1.1. 
Contour plots for E13.5, E14.5, and E15.5 are gated on all lymphoid cells. 
Note that the dot plots for E11.5 and E12.5 show stainings using anti-
CD45 and the contour plots for E13.5, E14.5 and E15.5 show stainings 
using anti-CD44. (C) EGFPCCR9 expression was analyzed in immature 
stages of adult T cell development. The contour plot shows DN stage 
thymocytes after electronic exclusion of cells expressing markers of 
lineage differentiation as in the E11.5 and E12.5 plots in (B). Histogram 
plots for DN1(CD44 CD25 ), DN2(CD44 CD25 ), intermediate DN2/
DN3(CD44lowCD25 ), and DN3(CD44 CD25 ) stage thymocytes of het-
erozygous CCR9-EGFP knock-in (thick line) and wild-type (thin line) mice 
are shown. Cell numbers are plotted relative to the channel with the 
highest number of cells. 
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concomitant presence of CCR9 protein or as evidence for
the involvement of CCR9 in thymus homing.
The analysis of heterozygous CCR9-EGFP knock-in
embryos revealed that significant amounts of tagged cells
were found only in the developing thymic anlage and the
fetal liver, the site of embryonic hematopoiesis (Fig. 1 A).
At embryonic day 11.5 (E11.5; the time when the first he-
matopoietic precursors arrive in the thymic anlage), all
hematopoietic cells in the developing thymic anlage
contained high levels of EGFP
 
CCR9
 
 (Fig. 1 B). The
first detectable immigrants contained higher amounts of
EGFP
 
CCR9
 
 than all subsequent stages of development up to
the occurrence of CD44-negative DN3/4 thymocytes at
E15.5. Already at E12.5, the population expressing
EGFP
 
CCR9
 
 at the level of E11.5 precursors represents only a
small fraction of all EGFP
 
CCR9
 
 
 
 cells. EGFP
 
CCR9
 
 expression
in heterozygous CCR9-EGFP knock-in mice also seems to
be regulated tightly during the early steps of adult thy-
mopoiesis. As observed during embryonic thymopoiesis,
EGFP
 
CCR9
 
 increases in adult, immature thymocytes that
progress from the CD44-positive DN2 to the CD44-nega-
tive DN3 stage (Fig. 1 C). Adult DN1 thymocytes show all
levels of EGFP
 
CCR9
 
 expression, from low to high, which
indicates phenotypic heterogeneity. EGFP
 
CCR9
 
 expression
among the DN stages is present throughout at least at low
levels.
 
Identification of EGFP
 
CCR9
 
-expressing thymic progenitors in 
bone marrow, blood, and thymus
 
Based on the embryonic analyses, we hypothesized that
EGFP
 
CCR9
 
 could be used in adult mice as a marker for the
most immature precursors in the thymus. Furthermore, we
postulated that EGFP
 
CCR9
 
 might identify T lineage biased pre-
cursors in the peripheral blood. This was crucial since the LSK
population has recently been shown to represent the only
population with potent T lineage potential in the blood of
adult mice (22) but conventional markers could not separate
thymic precursors from cells that are absent from the thymus
like self-renewing HSCs within this population. Therefore,
we investigated EGFP
 
CCR9
 
 expressing, thymus repopulating
cells in adult bone marrow, blood and thymus. In the bone
marrow, we identified a Lin
 
 
 
CD25
 
 
 
CD117
 
 
 
 EGFP
 
CCR9
 
 
 
population that contained all the in vivo thymus repopulating
activity among EGFP
 
CCR9
 
 
 
 bone marrow cells (Fig. S2, avail-
able at http://www.jem.org/cgi/content/full/jem.20050146/
 
Figure 2. Phenotypic and functional analysis of thymic progenitors 
found in bone marrow, peripheral blood and thymus of heterozygous 
CCR9-EGFP knock-in mice.
 
 (A) Lin
 
 
 
CD25
 
 
 
CD117
 
 
 
EGFP
 
CCR9
 
 
 
 cells found in 
bone marrow, peripheral blood, and thymus were analyzed for their ex-
pression of CD127(IL-7R
 
 
 
), Sca-1, CD4, CD90.2, and CD44. Contour plots 
are gated for lymphoid cells negative for B220, CD3
 
 
 
, CD8, CD25, CD11b, 
Gr-1, Ter119, TCR
 
 
 
, TCR
 
  
 
, and NK1.1 and histogram plots below show 
the cells in the indicated gates for each compartment. Cell numbers are 
plotted relative to the channel with the highest number of cells. (B) A 
five-color flow cytometric analysis of Lin
 
 
 
CD25
 
 
 
CD117
 
 
 
EGFP
 
CCR9
 
 
 
 bone 
marrow cells is shown in two color-coded contour plots. Both contour 
plots are gated on lineage marker–negative bone marrow cells, and the 
location of Lin
 
 
 
CD25
 
 
 
CD117
 
 
 
EGFP
 
CCR9
 
 
 
 cells is shown in blue. Within 
this population the Lin
 
 
 
CD25
 
 
 
CD117
 
 
 
EGFP
 
CCR9
 
 
 
CD127
 
-
 
/low
 
 bone marrow 
cells are shown in green, and the Lin
 
 
 
CD25
 
 
 
CD117
 
 
 
EGFP
 
CCR9
 
 
 
CD127
 
 
 
 
cells are shown in red. Lineage markers were defined as in (A). (C) 400 
Lin
 
 
 
CD25
 
 
 
CD117
 
 
 
EGFP
 
CCR9
 
 
 
 cells isolated from the peripheral blood of 
heterozygous CCR9-EGFP knock-in mice were FACS sorted as indicated in 
(A), and intrathymically injected into sublethally irradiated C57BL/6 mice. 
The contour plot shows the analysis of EGFP-positive thymocytes 19 d 
after intrathymic transfer. (D) 100 EGFP
 
CCR9
 
 
 
 bone marrow LSKs, 100 
EGFP
 
CCR9
 
 
 
Lin
 
 
 
CD25
 
 
 
CD117
 
 
 
 blood cells, 100 EGFP
 
CCR9
 
 
 
 thymic LSKs,
and their respective EGFP
 
CCR9
 
 
 
 counterparts were cultured on
OP9-DL1 stroma cells for 12 d. Histogram
 
 
 
plots are gated on 
CD19
 
 
 
NK1.1
 
 
 
CD90.2
 
 
 
 cells. The results of two independent experi-
ments are shown for each population. 
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DC1). The Lin
 
 
 
CD25
 
 
 
CD117
 
 
 
 EGFP
 
CCR9
 
 
 
 population
represents a subset of LSK and CLP precursors (Fig. S3, avail-
able at http://www.jem.org/cgi/content/full/jem.20050146/
DC1). Apart from this population, EGFP
 
CCR9
 
 
 
 bone mar-
row populations were found that lacked detectable T lineage
potential, which indicated that EGFP
 
CCR9
 
 expression in the
bone marrow is not restricted to thymic precursors.
Comparing Lin
 
 
 
CD25
 
 
 
CD117
 
 
 
EGFP
 
CCR9
 
 
 
 cells in bone
marrow, blood, and thymus revealed that only the CD127
(IL-7R
 
 
 
)-negative to low fraction among bone marrow
precursors appeared in blood and thymus (Fig. 2 A), which is
consistent with the reported absence of CLPs in blood (22)
and thymus (20). All other tested markers suggested pheno-
typic homogeneity among precursors in the different
compartments. Five-color FACS analyses revealed that the
CD127(IL-7R
 
 
 
)-negative to low fraction of bone marrow
Lin
 
 
 
CD25 CD117 EGFPCCR9  cells expresses high levels
of CD117(c-kit; Fig. 2 B); this is consistent with the pheno-
type of the same cells in the thymus which homogeneously
express high levels of CD117 (Fig. 2 A, top right). Thus, we
find evidence for the presence of a Lin CD25 CD117hi
EGFPCCR9 CD127 /lowSca-1hiCD4lowCD90.2 /lowCD44 
precursor population in heterozygous CCR9-EGFP
knock-in mice that is found in bone marrow, blood, and
thymus.
To find support for the idea that EGFPCCR9-tagged blood
LSKs are bound for the thymus, we investigated this popula-
tion in more detail. We detected only 30–60 of these precur-
sors in the blood of one mouse—and consistent with their
precursor phenotype—these cells gave rise to thymopoiesis in
vivo (Fig. 2 C). Functionally, the culture of blood precur-
sors on OP9-DL1 stroma cells revealed that Lin CD25 
CD117 EGFPCCR9  blood cells, but not their EGFPCCR9 
counterparts, contained T lineage precursors that gave rise to
CD90.2 EGFPCCR9  DN3/4 stage thymocytes (compare
with Fig. 1 C and Fig. S4, available at http://www.jem.org/
cgi/content/full/jem.20050146/DC1) within 12 d (Fig. 2 D).
DN3/4 stage thymocytes appeared in cultures of Lin CD25 
CD117 EGFPCCR9  blood precursors only after 16 d of
culture (unpublished data). Although both subsets contain T
lineage potential, all rapidly differentiating precursors are con-
tained in the EGFPCCR9  population. This indicated that
EGFPCCR9  blood LSKs are biased toward T cell develop-
ment relative to their EGFPCCR9  counterparts.
Figure 3. Kinetics of early T cell development in FTOC cultures 
of Lin CD25 CD117 EGFPCCR9  thymic precursors isolated from 
bone marrow, peripheral blood, and thymus. (A) 1,000 cells of the 
indicated phenotypes were FACS sorted from bone marrow and thymus 
as shown in Figs. 2 A and 3 B, and cultured together with a dGuo-
treated E15.5 fetal thymic lobe. Cultures seeded with peripheral blood 
Lin CD25 CD117 EGFPCCR9  cells were sorted as shown in Fig. 2 A and 
were initiated with 400–800 cells per lobe. FTOCs were analyzed at the 
indicated time points. Contour plots are gated on Lin  lymphoid cells 
and histogram plots are gated on Lin CD25  lymphoid cells. The results 
of three independent experiments for each subset and time point are 
shown. The median channel of EGFP fluorescence averaged over the 
three shown experiments is indicated. Coreceptor double-positive cells 
were found consistently in these cultures after 16 d. (B) The gates 
used for FACS sorting of thymic Lin CD25 CD117hiEGFPCCR9hi and 
Lin CD25 CD117hiEGFPCCR9low cells that were isolated for the FTOC 
experiments shown in (A) are indicated. The contour plot was defined 
as in Fig. 2 A.JEM VOL. 202, July 4, 2005 25
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Analysis of the kinetics of T cell development of
EGFPCCR9-expressing thymic progenitors
Our results suggest that the Lin CD25 CD117 EGFPCCR9 
population represents a thymus repopulating cell that travels
to the thymus via the blood. If this were true, one would ex-
pect that the thymic counterpart of this population is the
most immature precursor in the thymus and that cells iso-
lated from these compartments gave rise to more mature
stages of T cell development with similar kinetics. Based on
our embryonic analyses we further hypothesized that among
thymic Lin CD25 CD117hi EGFPCCR9  cells, which corre-
spond to the ETP population, the subset expressing the
highest levels of EGFPCCR9 represented the recent immi-
grants while cells with lower levels of EGFPCCR9 were more
mature. Indeed, thymic Lin CD25 CD117hi EGFPCCR9hi
precursors representing  20% of ETPs developed in fetal
thymic organ culture (FTOC) with kinetics that closely re-
semble those of circulating precursors from the blood (Fig.
3). In contrast, the wave of developing thymocytes that is
generated by the thymic Lin CD25 CD117hiEGFPCCR9low
Figure 4. Characterization of the differentiation potentials of 
thymic Lin CD25 CD117hi EGFPCCR9hi and EGFPCCR9low cells. (A) 500 
cells of the indicated phenotypes were cultured under serum-free condi-
tions on methylcellulose containing IL-7, SCF, and Flt3L for 5 d, after 
which the number of living cells per cell plated was determined. Mean 
and standard deviation of three independent experiments are shown for 
each cell type. (B) Pools of 2,000 cells of the indicated phenotype were 
cultured on a layer of OP9 or ST2 stromal cells in the presence of IL-7, 
SCF, Flt3L, and IL-2 and analyzed at the indicated time points. Empty 
plots indicate absence of living cells. The percentages for the respective 
quadrants are shown. (C) The frequency of B cell precursors among thy-
mic Lin CD25 CD117hiEGFPCCR9hi and EGFPCCR9low cells was determined 
by limiting dilution assays. Both cell types were sorted in pools of 20, 40, 
and 80 cells (n   30) onto OP9 stromal layers and cultured for 9 and 12 d, 
respectively. The failure to detect B lymphopoiesis is plotted. (D) RT-PCR 
analyses on RNA isolated from thymic Lin CD25 CD117hiEGFPCCR9hi 
(EGFPhi) cells and total bone marrow cells (control) with primers specific 
for the indicated transcripts. Mock RT-PCR samples remained negative. 
(E) Phenotypic analysis of cells derived from a representative culture of 
Lin CD25 CD117hiEGFPCCR9hi cells on an ST2 stromal cell layer. No difference 
was found between cultures of thymic Lin CD25 CD117hiEGFPCCR9hi and 
EGFPCCR9low cells. Contour plots on the left are gated on lymphoid cells 
and show the results of one multiparameter FACS analysis demonstrat-
ing the presence of dendritic cells. Contour plots on the right are gated 
on large, complex, immature myeloid cells and also show the results 
derived from one multiparameter staining. (F) The morphology of cells in 
cultures of thymic precursors on ST2 stromal cell layers was determined 
for a culture that contained predominantly immature myeloid cells as 
shown in (E, right panels) by staining of cells spun onto a glass slide 
according to Pappenheim. The majority of cells showed a blast-like 
morphology (top left) and some resembled bone marrow myeloblasts 
(bottom left). Few mature granulocytes also were observed (e.g., a neu-
trophilic granulocyte [top right] and a basophilic granulocyte [bottom 
right]). Bar, 10  m.A MULTIPOTENT PRECURSOR IN THE THYMUS | Benz and Bleul 26
population had progressed significantly beyond the DN2
stage after 8 d, which indicated a more differentiated state of
this subset. Thus, the EGFPCCR9 tag allowed us to identify
subsets within the ETP population that showed distinct lev-
els of maturity. Specifically, the data demonstrate that adult
thymic Lin CD25 CD117hiEGFPCCR9hi precursors are less
mature than their EGFPlow counterparts, and that phenotyp-
ically identical precursors that show a similar state of imma-
turity exist in the blood.
Analysis of the differentiation potential of
EGFPCCR9-expressing thymic precursors
To address the question of lineage relationship between he-
matopoietic cells in the thymus, we investigated the growth
requirements and the differentiation potential of thymic
EGFPCCR9-expressing precursors within the ETP population.
Although CLPs and bone marrow precursors contained in the
LSK compartment proliferated vigorously in the presence of
stem cell factor (SCF), Flt3L, and IL-7 under serum-free con-
ditions as previously reported (5, 6), numbers of thymic
Lin CD25 CD117hiEGFPCCR9hi precursors declined rapidly
over a period of 5 d of culture under these conditions (Fig. 4
A). This observation indicated that these progenitors are func-
tionally distinct from other short-term repopulating cells that
are found in the bone marrow LSK population (5).
Lin CD25 CD117hiEGFPCCR9hi precursors did proliferate in
vitro when they were sorted in pools of 2,000 cells onto layers
of the bone marrow stroma cell line OP9 in the presence of
SCF, Flt3L, IL-7, and IL-2 (Fig. 4 B). Under these conditions
they gave rise to NK and B cells. This is in contrast to the dif-
ferentiation potential of the recently described ETP sub-
sets, DN1a and DN1b, which do not produce B cells (26)
but is consistent with the reported B cell potential when
unseparated ETPs were assayed (20). Lin CD25 CD117hi
EGFPCCR9hi precursor–derived B cells consistently required
12 d to develop. In rare cases, pools of 2,000 thymic
Lin CD25 CD117hiEGFPCCR9low cells also produced B cells;
however, these cells were detected considerably earlier
than in cultures of the EGFPCCR9hi counterpart, supplying
further evidence for the more differentiated state of thymic
Lin CD25 CD117hiEGFPCCR9low cells (Fig. 4 B). Limiting
dilution assays revealed that only the Lin CD25 CD117hi
EGFPCCR9hi population contained significant capacity to gen-
erate B lymphocytes. Although 1 in 32 of these cells gave rise
to a colony of B cells on cytokine-supplemented OP9 layers,
we did not find a single B cell colony in the cultures of 4,200
thymic Lin CD25 CD117hiEGFPCCR9low cells (Fig. 4 C).
ETPs that contain both of these precursors are believed
to consist mainly of T lineage precursors with a few B
progenitors. Therefore, our observation could be explained
by the presence of a few committed B cell precursors within
the Lin CD25 CD117hiEGFPCCR9hi population. How-
ever, RT-PCR analyses of sorted Lin CD25 CD117hi
EGFPCCR9hi cells did not detect transcripts indicative of B
cell commitment, such as Pax5 or  5 (Fig. 4 D). These
findings demonstrate that only the most immature pre-
cursors in the thymus possess B cell potential, and that
committed B precursors are undetectable within this
population.
To our surprise, both precursors gave rise to myeloid
cells. When we cultured Lin CD25 CD117hiEGFPCCR9hi
and EGFPCCR9low cells as pools of 1,000 cells on the bone
marrow stromal cell line ST2 in the presence of SCF, Flt3L,
IL-7, and IL-2 we observed the growth of CD11b-positive
cells for both types of precursors in nine out of nine experi-
ments (Fig. 4 B). Cytokine-supplemented ST2 cultures from
both precursors were indistinguishable in that they contained
“myeloid” and “lymphoid” dendritic cells as well as imma-
ture myeloid cells, and a few mature granulocytes (Fig. 4, E
and F). We then investigated the possibility that thymic pre-
cursors induced detectable granulopoiesis in the thymus but,
consistent with a previous report (20), could not find signifi-
cant numbers of cells with the surface markers that are char-
acteristic for common myeloid progenitors, megakaryocyte/
erythrocyte lineage-restricted progenitors, and granulocyte/
macrophage lineage-restricted progenitors (31) that have
been shown to give rise to all myeloid lineages (unpublished
data). Therefore, we conclude that although both precursors
possess granulocytic differentiation potential in vitro, it is
suppressed in the thymic microenvironment in vivo. Collec-
tively, we find that apart from T cells, thymic precursors give
rise to B cells, NK cells, dendritic cells, and myeloid cells;
this is consistent with most reports (8, 9, 13, 20, 21, 26, 32)
but is at odds with another (33). Significantly, the presented
data show that only the capacity to generate B cell develop-
ment ultimately is restricted to the most immature precursor
in the thymus, whereas all other lineages still can be pro-
duced effectively by a more differentiated precursor. Because
the thymic Lin CD25 CD117hiEGFPCCR9hi progenitor
gives rise to mature cells of multiple hematopoietic lineages,
we termed it “thymic multipotent precursor” (TMP).
Clonal analysis of thymic multipotent progenitors
Based on the finding that immaturity among thymic precur-
sors correlated with the most diverse differentiation capacity,
we investigated the possibility that all hematopoietic lineages
that develop in the thymus (namely T cells, B cells, and den-
dritic cells) are derived from a single precursor. The potential
to give rise to granulocytic cells was not investigated further
because there is no evidence for ongoing granulopoiesis in
the thymus. Alternatively, immigration of committed, lin-
eage-restricted precursors could be the prevailing mode of
supply for adult thymopoiesis which would be consistent
with the common assumption that immature thymic precur-
sors contain mainly T lineage precursors and a few B and
myeloid progenitors (i.e., we investigated the question if
thymic precursors commit to the T cell lineage within or
outside the thymus). To address this question we cultured
thymic precursors on 20:1 mixtures of the OP9 bone mar-
row stroma cell line (34) and its derivative, the OP9-DL1JEM VOL. 202, July 4, 2005 27
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cell line (35). This mixture supports the differentiation of
precursor cells into T and B cells in one and the same well
(Fig. 5 A). TMPs were double-sorted to a purity of  99.9%
and placed as single cells onto OP9/OP9-DL1(20:1) layers
in a 96-well format. We consistently found T and B cells in
1 to 3 wells out of 95 wells to which a single TMP had been
added (Fig. 5 B and Table I, A1–A3). This experiment dem-
onstrates that the TMP population contains bipotent T/B
precursors and that thymic precursors exist that commit to
the T cell lineage only after thymus entry. Despite the long
period of physiologically unfavorable conditions during cell
isolation and double-sorting,  50% of the double-sorted
TMPs gave rise to T cell colonies on OP9-DL1 stromal lay-
ers (Table I, B1). Strikingly, single TMPs sorted on OP9/
OP9-DL1(20:1) stromal layers frequently gave rise to T cells
only, whereas wells that contained only B cells were seen
rarely (Table I, A1–A3). This constellation makes the
possibility that the T and B cells found in one and the
same well originated from two independent, lineage-
restricted precursor cells highly unlikely. Single cells giving
rise to T and B cells also were found among the few
Lin CD25 CD117 EGFPCCR9  cells in the blood, which
further supported the notion of a bipotent T/B precursor
colonizing the thymus (Table I, C1 and C2). Again, the low
frequency of wells containing only T or only B cells ruled
out the possibility that wells containing B and T cells are the
result of the erroneous addition of two independent precur-
sors to the same well. To investigate the question if the
bipotent T/B progenitor found among TMPs also produced
dendritic cells, we split OP9/OP9-DL1(20:1) cultures de-
rived from single TMPs onto methylcellulose containing IL-1,
IL-3, IL-6, SCF, and Flt3L in the absence of serum. After
4 to 5 d, these cultures contained small but significant num-
bers of dendritic cells (Fig. 5 B). This observation is con-
sistent with our previous finding that dendritic cells can be
derived in vitro from more mature stages of T cell develop-
ment (Fig. 4 B), and demonstrates that a single hematopoie-
tic precursor—which can be found among TMPs in het-
erozygous CCR9-EGFP knock-in mice—gives rise to all three
hematopoietic lineages that develop in the thymus.
Finally, we investigated Lin CD25 CD117hi thy-
mocytes of wild-type mice for bipotent T/B progenitors as
the defining feature of TMPs. In a representative experiment
we found two progenitors that gave rise to B and T cells
among 475 singly sorted cells using the OP9/OP9-DL1(20:1)
culture system (Table I, D1). Thus, bipotent thymic pro-
genitors identified in heterozygous CCR9-EGFP knock-in
mice also can be found in wild-type mice.
DISCUSSION
The presented data demonstrate for the first time that single
hematopoietic precursor cells can be isolated from the adult
thymus that give rise to T, B, and dendritic cells (i.e., the
three hematopoietic lineages known to develop in the thy-
mus; references 7–9, 36). The fact that all three lineages can
be derived from a single precursor indicates that thymic pre-
cursors exist that enter the thymus as multipotent progeni-
tors and commit to the T cell lineage only within the thymic
microenvironment. That adult thymic precursors have the
capacity to give rise to hematopoietic cells of multiple lin-
eages has long been known (8, 9, 13, 20, 21, 26, 32). These
Figure 5. Analysis of the differentiation potential of TMPs on the 
single cell level. (A) 100 TMPs were cultured on stromal layers of OP9, 
OP9-DL1, or a mixture of OP9/OP9-DL1 (20:1) in the presence of IL-7, SCF, 
Flt3L, and IL-2 for 12 d. At that time, cultures were analyzed by FACS. 
Contour plots in the middle are gated on NK1.1 CD19  cells found in the 
bottom left quadrants of contour plots on the left. Contour plots on the 
right are gated on cells lacking the markers CD4, CD8, and CD3  (triple-
negative cells). The percentages for the respective quadrants are shown. 
Coreceptor double-positive cells were found in cultures on OP9-DL1 stro-
mal cell layers after 16–19 d. (B) Double-sorted, single TMPs were placed 
into the wells of a 96-well plate onto OP9/OP9-DL1 (20:1) stromal cell 
layers and cultured as in (A). The reanalysis of TMPs double-sorted to a 
purity of  99.9% is shown (top left contour plot). Single TMPs that were 
transferred after 12 d from the OP9:OP9-DL1 mixture onto a fresh layer of 
OP9-DL1 cells generated double-positive cells after 16–19 d of culture 
(top right contour plot). To demonstrate that T, B, and dendritic cells could 
be derived from a single cell, productive cultures were split after 10 d onto 
methylcellulose containing IL-1 , IL-3, IL-6, SCF, and Flt3L. OP9/OP9-DL1 
cultures were analyzed after 12 d (bottom left and middle panel) and 
methylcellulose cultures were analyzed 4 d after the split (bottom right 
panel). The bottom panels show the results of one representative singly-
sorted TMP. The bottom middle contour plot is gated on NK1.1 CD19  
cells found in the bottom left quadrant of the bottom left contour plot.A MULTIPOTENT PRECURSOR IN THE THYMUS | Benz and Bleul 28
reports suggested that multipotent progenitors enter the thy-
mus, but it had not been demonstrated that the relevant lin-
eages in the thymus all can be derived from a single cell. Our
observation that multipotent precursors are found exclu-
sively among the most immature precursors in the thymus
and in the peripheral blood supports the idea of a multipo-
tent precursor that repopulates the thymus. These findings
change the way we think of precursors in the thymus. Previ-
ously, it had been assumed that thymic precursors consist of
mainly T lineage cells together with a few B and myeloid
progenitors. In line with this notion, a recent report sug-
gested the independent immigration of B precursors and the
most immature T lineage progenitors within separate pre-
cursor populations (26). In contrast, our data now suggest
that thymic precursors in the heterogeneous ETP population
(23, 26) represent distinct levels of T cell commitment. The
most immature stages are multipotent precursors with the in
vitro capacity to give rise to T, B, NK, myeloid/granulo-
cytic, and dendritic cells, and the most differentiated cells are
T lineage committed—similar to cells that can be found in
the DN2/3 stages.
The isolation of multipotent precursors in the thymus re-
quired the identification of the most immature precursor in
the thymus within the ETP population. We identify thymic
Lin CD25 CD117hiEGFPCCR9hi progenitors, which we
term TMPs, as an ETP subset that shows nearly identical de-
velopmental kinetics as thymic precursors in the blood, and
leaves little space for thymic precursors that might be even
more immature. TMPs represent  20% of ETPs and are
functionally distinct from the remaining ETPs outside of the
TMP gate. Only TMPs show nearly identical developmental
kinetics as their counterparts in the blood and contain signif-
icant B lineage potential. Given the fact that the CD4low pre-
cursor and the ETP population are vastly overlapping popu-
lations that are functionally indistinguishable from each
other, the identification of the TMP represents a major ad-
vance in our understanding of early T cell development. We
find   1,000 TMPs per thymus of a 4–5-wk-old mouse
which is consistent with the notion that TMPs represent
a small subset of the ETPs. The Lin CD25 CD117hi
EGFPCCR9low precursor, which represents a closely related,
more differentiated version of the TMP, also is contained in
the ETP population. It has lost its capacity to produce B cells
which indicates that the TMP maps to the branching point
of the T versus B lineage decision in the hematopoietic lin-
eage hierarchy. This more differentiated precursor still pro-
duces granulocytic cells in vitro, although granulopoiesis is
not observed in vivo. This finding suggests that the T versus
B cell lineage decision precedes the loss of myeloid potential
in early thymic precursors.
A single thymic precursor can give rise to more than 105
thymocytes in FTOCs (37), conditions which are presum-
ably far from optimal when compared with the in vivo situa-
tion. Thus, less than 1,000 precursors theoretically should be
enough to generate the 1–2   108 thymocytes found in
young adult mice. There is experimental evidence that the
thymic niche that holds the repopulating precursors contains
 200 cells that remained phenotypically uncharacterized
(24, 25). This is close to the 1,000 TMPs that we find per
thymus of a 4–5-wk-old mouse. The low number of thymic
precursor cells that is required to maintain thymopoiesis may
explain why the search for the thymus-repopulating precur-
sor has proven to be the search for the proverbial needle in
the haystack. Our work introduces the heterozygous
CCR9-EGFP knock-in mouse as a tool to study the earliest
steps of thymopoiesis. We (30) and others (38, 39) have
studied adult   -T cell development in homozygous and
heterozygous CCR9-deficient mice extensively. No evi-
dence for a nonredundant role for CCR9 in the immigra-
tion of hematopoietic precursors into the thymus was found.
Table I. Single cell analysis of double-sorted thymic precursors
Progenitors for
Experiment
no.
Cell type of
sorted cells Mouse strain Stromal layer
No. of 
single cells
sorted T cells B cells
T and B
cells
A1 TMP heterozygous CCR9-EGFP
knock-in
OP9/OP9-DL1 (20:1) 95 8 0 1
A2 TMP heterozygous CCR9-EGFP
knock-in
OP9/OP9-DL1 (20:1) 95 8 1 3
A3 TMP heterozygous CCR9-EGFP
knock-in
OP9/OP9-DL1 (20:1) 95 7 1 2
B1 TMP heterozygous CCR9-EGFP
knock-in
OP9-DL1 95 47 0 0
C1 peripheral blood
Lin CD25 CD117 EGFP  cells 
heterozygous CCR9-EGFP
knock-in
OP9/OP9-DL1 (20:1) 95 0 1 7
C2 peripheral blood
Lin CD25 CD117 EGFP  cells
heterozygous CCR9-EGFP
knock-in
OP9/OP9-DL1 (20:1) 95 4 0 2
D1 Lin CD25 CD117hi thymocytes wild-type OP9/OP9-DL1 (20:1) 475 26 3 2JEM VOL. 202, July 4, 2005 29
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In this study we used the CCR9-EGFP knock-in allele like
a surface marker of unknown function to identify distinct
thymus-repopulating precursors without implying any role
for CCR9 in thymus homing. Only two abnormalities have
been described in CCR9-deficient mice which affect adult
  -T cell development; neither are found in the heterozy-
gous EGFP-CCR9 knock-in mice that were used in this
study. First, CCR9-deficient bone marrow repopulates the
thymus inefficiently in competitive transfer experiments
(39). Our own competitive transfer experiments confirm this
finding, but show no significant difference for heterozygous
mice (Table S1, available at http://www.jem.org/cgi/
content/full/jem.20050146/DC1). Second, immature thy-
mocytes do not home to the subcapsular microenvironment
in CCR9-deficient thymi but do so in heterozygous CCR9-
EGFP knock-in and wild-type mice (30). Furthermore, the
finding that bipotent precursors give rise to T and B cell de-
velopment, a capacity that characterizes the TMP in het-
erozygous CCR9-EGFP knock-in mice, is also found
among wild-type Lin CD25 CD117hi thymocytes further
supports the validity of the CCR9-EGFP knock-in model.
Although the characterization of thymic precursors in
bone marrow and blood helped us to identify immature pre-
cursors in the thymus and to investigate their differentiation
potential, many questions concerning thymus repopulation
remain. Our experiments do not rule out the possibility that
TMP-independent precursors exist in the thymus because we
followed cells that expressed the EGFPCCR9 tag exclusively.
Thus, precursors from distinct levels of the hematopoietic hi-
erarchy may enter the thymus independently of TMPs, and
these may be precommitted to one or the other lineage.
In summary, our work identifies a rare thymic precursor
that gives rise to all hematopoietic lineages found in the thy-
mus. It maps to the branching point of the T versus B lineage
decision—a key developmental position in hematopoietic lin-
eage maps. The study of this cell will add significantly to our
understanding of hematopoiesis because this is the cell type
that makes the T versus B cell fate decision in the context of
the thymic microenvironment under physiologic conditions.
MATERIALS AND METHODS
Mice. BALB/c, C57BL/6, C57BL/6-Ly5.1, RAG2-deficient, CCR9-
EGFP knock-in, and RAG2-deficient CCR9-EGFP knock-in mice were
kept under specific pathogen-free conditions in the mouse facility of the
Max-Planck-Institute for Immunobiology. Embryos were obtained from
timed pregnant mice and the day of the vaginal plug was counted as day 0.5
of pregnancy. 3–6-wk-old mice were used for experiments unless otherwise
indicated. Because the highest numbers of TMPs were recovered from 4–5-
wk-old mice, such mice were used for sorting TMPs from bone marrow,
blood, and thymus. Experimentation and animal care was in accordance
with the guidelines of the Max-Planck-Institute for Immunobiology.
Flow cytometric analysis. Cells were prepared and stained as described
previously (40). Peripheral blood was obtained from the axilla of anesthe-
tized mice. Bone marrow and blood cells were incubated with 1  g mAb
2.4G2 per 106 cells (provided by M. Lamers, Max-Planck-Institute for Im-
munobiology, Freiburg, Germany) for 10 min on ice before staining. Den-
dritic cells and immature myeloid cells derived from ST2 cultures were in-
cubated with a 1:5 dilution of normal rat serum and 1  g 2.4G2 for 10 min
on ice before staining. The following PE, PE-Cy5, PE-Cy7, APC,
AlexaFluor647, or biotin-conjugated monoclonal antibodies were used
(clone names given in parentheses) from BD Biosciences: anti-CD3  (145–
2C11), anti-CD4 (GK1.5), anti-CD8  (53–6.7), anti-CD8  (H35-17.2),
anti-CD11b (M1/70), anti-CD11c (HL3), anti-CD25 (PC61), anti-CD44
(IM7), anti-CD45 (30-F11), anti-CD90.2 (53–2.1), anti-TCR ; (H57–
597), anti-TCR   (GL3), anti-NK1.1 (PK136), anti-Ter119 (Ly-76), and
anti-Gr1 (RB6-8C5); from eBioscience: anti-CD117 (2B8), anti-CD127
(A7R34), anti-Sca-1 (D7); and from Caltag: anti-IgM (polyclonal). The bi-
otin label was visualized using SA-PE-Cy5 (Invitrogen) or SA-APC-Cy7
(eBioscience) conjugates. Stainings were analyzed on a FACSCalibur or an
LSRII machine (both obtained from BD Biosciences).
Cell sorting and RT-PCR analysis. To deplete single cell suspensions
of lineage marker–positive cells before cell sorting, thymocytes and bone
marrow cells were incubated with unlabeled anti-CD8 (169.4.2, provided
by M. Lamers) and with unlabeled mAbs directed against Ter119, B220 and
Gr-1 (all BD Biosciences), respectively. Lineage marker–positive cells were
depleted using goat anti–rat IgG-conjugated paramagnetic beads and MACS
separation CS columns according to the manufacturer’s recommendations
(Miltenyi Biotec). The purified cells were stained and sorted on a high-
speed FACS sorter (MoFlo; DakoCytomation) to a purity of  98%. For
single cell isolation, sorted cells were sorted a second time. The secondary
sort was done in single cell sort mode into 96-well plates at a flow rate of 5–20
cells/s. Purity of double-sorted cells was determined for each experiment
and consistently was  99.9%. RT-PCR on RNA isolated from 10,000
sorted cells of each subset was done as previously reported (41) using primers
described earlier (42, 43). All mock RT-PCR samples remained negative.
Adoptive transfer experiments. Thymi of injected mice were analyzed
22 d after i.v. injection by FACS analysis. Intrathymic transfers of 400 cells
sorted from the blood were done together with 15,000 RAG2-deficient
carrier cells in a volume of 10  l into anesthetized C57BL/6 mice that had
been sublethally irradiated with 450 rad 24 h earlier. Thymi of intrathymi-
cally transferred mice were analyzed after 19 d.
Fetal thymic organ culture. FTOCs were set up as described previously
(13). Because of the low numbers of Lin CD25 CD117 EGFPCCR9  cells
that can be isolated from the peripheral blood, these cells were cultured in
FTOCs together with 5,000 RAG2-deficient thymocytes. The rare cases in
which either Balb/c (from the embryonic thymus) or RAG2-deficient car-
rier cells repopulated an FTOC could be identified by the EGFPCCR9 ex-
pression found in DN2- and DN3-stage thymocytes derived from EGFP-
CCR9 knock-in mice. DN2 thymocytes in these mice show low-level
EGFPCCR9 expression (Fig. 1 C).
Cytospin and hematologic staining. Cells were spun onto glass slides
and stained according to Pappenheim. In brief, cells were fixed in May-
Grünwald solution (Sigma-Aldrich) for 2 min at RT, washed first with dis-
tilled water, and then tap water before 15 min of staining with a 1:20 dilu-
tion of Giemsa solution (Sigma-Aldrich).
In vitro cultures of thymic progenitor cells. For the culture of thy-
mic progenitor cells layers of OP9 (provided by M. Kondo, Duke Univer-
sity, Durham, NC) and OP9-DL1 (provided by J.C. Zuniga-Pflücker, Uni-
versity of Toronto, Toronto, Ontario, Canada) stromal cells and mixtures of
OP9 and OP9-DL1 cells were plated at 2   103 cells per 96-well plate 48 h
before progenitors were sorted. Irradiated (3000 rad) ST2 bone marrow
stromal cells were seeded at 104 cells per 96-well plate. 24 h before cell sort-
ing, the cell culture medium was replaced by RPMI 1640 containing 10%
FCS, 2 mM L-glutamin, 100 U/ml penicillin, 100  g/ml streptomycin, 1
mM sodium pyruvate, and 2   10 5 M  -mercaptoethanol. Thymic pro-
genitors were sorted onto the different stromal cell layers, and progenitors
were cultured in the presence of recombinant, murine IL-7, Flt3L, SCF (10A MULTIPOTENT PRECURSOR IN THE THYMUS | Benz and Bleul 30
ng/ml each; R&D Systems), and 50 ng/ml recombinant, human IL-2 (Pep-
rotech) at 37 C in a humidified chamber and 5% CO2. At the indicated
time points, cultures were analyzed by FACS. For ST2 cultures, adherent
hematopoietic cells were detached by incubation with PBS/0.3% BSA/5
mM EDTA for 10 min to generate single cell suspensions. LSKs
(Lin CD127 Sca-1hiCD117hi), CLPs (Lin CD127 Sca-1lowCD117low),
and TMPs were cultured on methylcellulose containing IL-7 (10 ng/ml;
Methocult M3630, StemCell Technologies Inc.) supplemented with re-
combinant SCF (100 ng/ml) and Flt3L (20 ng/ml; both obtained from
R&D Systems). Differentiation of thymic progenitors toward dendritic cells
was achieved by splitting OP9/OP9-DL1 (20:1) cultures at day 10 onto
methylcellulose (Methocult M3231, StemCell Technologies Inc.) supple-
mented with recombinant, murine IL-1  (5 ng/ml), IL-3 (50 ng/ml), IL-6
(10 ng/ml), SCF (30 ng/ml), and Flt3L (30 ng/ml; all R&D Systems). Cells
were analyzed by FACS after 4 d in culture.
Online supplemental material. Fig. S1 identifies EGFP-expressing cells
in heterozygous EGFP-CCR9 knock-in mice. Fig. S2 characterizes the in
vivo thymus-repopulating capacity of EGFPCCR9  populations in the bone
marrow. Fig. S3 shows the fraction of EGFPCCR9-expressing cells among CLPs
and LSKs. Fig. S4 demonstrates that NK1.1 CD90.2 EGFPCCR9  found in
OP9-DL1 cultures represent DN3/4 stage thymocytes. Table S1 shows the re-
sults of competitive transfer experiments of wild-type versus heterozygous
EGFP-CCR9 knock-in bone marrow. Online supplemental material is avail-
able at http://www.jem.org/cgi/content/full/jem.20050146/DC1.
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